Scientists target growth switch to halt bowel and liver cancers
Glasgow scientists identify blocking the NPM1 protein, linked to the WNT signaling pathway, as a potential way to stop growth in bowel and certain liver cancers; removing NPM1 impairs cancer cells’ protein production and may reactivate tumor-suppressing mechanisms, offering a possible avenue for new therapies.